Drugs / Eschscholzia californica Herba rec. tinct. conc.
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT06795776 | Apr → Nov 2025 | — | A. Vogel AG | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Eschscholzia californica Herba rec. tinct. conc. | “0.503g Eschscholzia californica Herba rec. tinct. conc. as the active pharmaceutical ingredient (API)” NCT06795776 ↗ |
| Route | Oral | “The intervention will be provided as swallowable "Eschscholzia tablets"” NCT06795776 ↗ |